These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7936174)

  • 21. Use of the magnetic resonance contrast agent gadodiamide in the central nervous system. Results of a multicenter trial.
    Sze G; Brant-Zawadzki M; McNamara MT; Haughton VM; Kumar AJ; Maravilla KR; Aisen AM; Dreisbach JN; Bradley WG; Weinreb JC
    Invest Radiol; 1993 Mar; 28 Suppl 1():S49-55. PubMed ID: 8486504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of dotarem (Gd-DOTA) versus magnevist (Gd-DTPA) in magnetic resonance imaging of the central nervous system.
    Oudkerk M; Sijens PE; Van Beek EJ; Kuijpers TJ
    Invest Radiol; 1995 Feb; 30(2):75-8. PubMed ID: 7782190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double blind study to evaluate the tolerability of gadodiamide injection and its effect on renal function in patients undergoing cerebral magnetic resonance imaging.
    Lundby B; Berg KJ; Lien HH; Aamdal S
    Br J Radiol; 1993 Oct; 66(790):871-6. PubMed ID: 8220968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MR imaging of pituitary region lesions with gadodiamide injection.
    Hald JK; Skalpe IO; Bakke SJ; Nakstad PH
    Acta Radiol; 1994 Jan; 35(1):65-9. PubMed ID: 8305277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain lesion contrast in MR imaging. Dependence on field strength and concentration of gadodiamide injection in patients and phantoms.
    Akeson P; Vikhoff B; Ståhlberg F; Holtås S
    Acta Radiol; 1997 Jan; 38(1):14-8. PubMed ID: 9059395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and tolerance after intravenous administration of 0.3 mmol/kg Gd-DTPA. Results of a randomized, controlled clinical trial.
    Niendorf HP; Haustein J; Louton T; Beck W; Laniado M
    Invest Radiol; 1991 Nov; 26 Suppl 1():S221-3; discussion S232-5. PubMed ID: 1808134
    [No Abstract]   [Full Text] [Related]  

  • 27. Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence.
    Reimer P; Rummeny EJ; Shamsi K; Balzer T; Daldrup HE; Tombach B; Hesse T; Berns T; Peters PE
    Radiology; 1996 Apr; 199(1):177-83. PubMed ID: 8633143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomised double blind trial of the safety and efficacy of two gadolinium complexes (Gd-DTPA and Gd-DOTA).
    Brugières P; Gaston A; Degryse HR; Parizel PM; de Schepper AM; Berry I; Manelfe C; Le Bras F; Marsault C; Wichmann W
    Neuroradiology; 1994; 36(1):27-30. PubMed ID: 8107991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance].
    Campos A; Aznar L; Alamar R; Castelló JV
    Med Clin (Barc); 1996 Feb; 106(5):197. PubMed ID: 8684023
    [No Abstract]   [Full Text] [Related]  

  • 30. Contrast-enhanced MRI with gadodiamide injection in rat disease models.
    Yamada K; Miyahara K; Sato H; Nakayama W; Sato M; Hirose T; Kato H; Ikehira H; Tateno Y; Sugihara H; Furuhama K
    J Vet Med Sci; 1996 Apr; 58(4):291-5. PubMed ID: 8741259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interference of gadodiamide injection (OMNISCAN) on the colorimetric determination of serum calcium.
    Normann PT; Frøysa A; Svaland M
    Scand J Clin Lab Invest; 1995 Aug; 55(5):421-6. PubMed ID: 8545600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement of relative cerebral blood volume changes with visual stimulation by 'double-dose' gadopentetate-dimeglumine-enhanced dynamic magnetic resonance imaging.
    Frank JA; Mattay VS; Duyn J; Sobering G; Barrios FA; Zigun J; Sexton R; Kwok P; Woo J; Moonen C
    Invest Radiol; 1994 Jun; 29 Suppl 2():S157-60. PubMed ID: 7928216
    [No Abstract]   [Full Text] [Related]  

  • 33. MR diagnosis of head and neck tumors: comparison of contrast enhancement with triple-dose gadodiamide and standard-dose gadopentetate dimeglumine in the same patients.
    Vogl TJ; Mack MG; Juergens M; Stark M; Pegios W; Bergman C; Grevers G; Western A
    AJR Am J Roentgenol; 1994 Aug; 163(2):425-32. PubMed ID: 8037044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodynamic effects of bolus injection of gadodiamide injection and gadopentetate dimeglumine as contrast media at MR imaging in rats.
    Mühler A; Saeed M; Brasch RC; Higgins CB
    Radiology; 1992 May; 183(2):523-8. PubMed ID: 1561362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contrast-enhanced magnetic resonance angiography of the lower extremities: standard-dose vs. high-dose gadodiamide injection.
    Krause U; Kroencke T; Spielhaupter E; Taupitz M; Kenn W; Hamm B; Hahn D
    J Magn Reson Imaging; 2005 Apr; 21(4):449-54. PubMed ID: 15778953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemodynamic effects of gadodiamide injection and gadopentetate dimeglumine in anesthetized dogs.
    Peters JL; Shaw DD
    Acta Radiol; 1993 Sep; 34(5):510-6. PubMed ID: 8369191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Gadodiamide and gadolinium-DTPA as intravenous media in computed tomography].
    Engelbrecht V; Koch JA; Rassek M; Mödder U
    Rofo; 1996 Jul; 165(1):24-8. PubMed ID: 8765359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.
    Haustein J; Laniado M; Niendorf HP; Louton T; Beck W; Planitzer J; Schöffel M; Reiser M; Kaiser W; Schörner W
    Radiology; 1993 Mar; 186(3):855-60. PubMed ID: 8430199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MR imaging in recurrent pain after back surgery. A comparative study using standard and high doses of gadolinium contrast agents.
    Akeson P; Annertz M; Kristoffersen DT; Jonsson E; Holtas S
    Acta Radiol; 1996 Nov; 37(6):858-62. PubMed ID: 8995455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent.
    Harpur ES; Worah D; Hals PA; Holtz E; Furuhama K; Nomura H
    Invest Radiol; 1993 Mar; 28 Suppl 1():S28-43. PubMed ID: 8486501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.